Latest News

The handover ceremony took place at the Kenya BioVax headquarters and was presided over by Dr. Charles Githinji, the Chairman of the Board of Directors.

The WHO’s African Regional Verification Commission for Measles and Rubella Elimination verified this achievement following its October 2025 meeting in Johannesburg, South Africa.

The agreement encompasses the manufacturing and supply of several Algorithm products licensed in the European Union and Japan.

Africa Genome Archiving for Response and Insight (AGARI) is a collaborative initiative developed in partnership with the African Society for Laboratory Medicine (ASLM) and African Union Member States.

This project marks the first hospital of its kind in the Gulf region, blending medical excellence with advanced urban planning.

Researchers at Jaramogi Oginga Oginga Teaching and Referral Hospital (JOOTRH) tested 256 fish samples and found 153 positive for E. coli.

This collaboration establishes a comprehensive framework designed to strengthen pediatric services throughout Dubai Health’s extensive network of medical facilities.

GEN1160 now joins GEN1107 on Genmab’s list of discontinued assets from the April 2024 ProfoundBio acquisition.

The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).

The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.